Uniphar (LON:UPR) Stock Rating Reaffirmed by Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft reaffirmed their buy rating on shares of Uniphar (LON:UPR) in a research report released on Wednesday morning, Marketbeat reports. They currently have a GBX 310 ($4.08) price target on the stock.

Uniphar Price Performance

Shares of LON UPR opened at GBX 221 ($2.91) on Wednesday. The firm has a market cap of £603.37 million, a P/E ratio of 1,578.57 and a beta of 0.77. The business’s 50 day moving average is GBX 217.21 and its 200-day moving average is GBX 222.56. The company has a current ratio of 0.88, a quick ratio of 0.60 and a debt-to-equity ratio of 114.50. Uniphar has a 1-year low of GBX 178 ($2.34) and a 1-year high of GBX 256 ($3.37).

Uniphar Cuts Dividend

The company also recently announced a dividend, which will be paid on Friday, October 4th. Stockholders of record on Thursday, September 12th will be issued a dividend of €0.01 ($0.01) per share. This represents a dividend yield of 0.25%. The ex-dividend date of this dividend is Thursday, September 12th. Uniphar’s dividend payout ratio is currently 1,428.57%.

About Uniphar

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers.